| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $308.2M | — | +44.4% |
| R&D Expense | $80.1M | — | +38.5% |
| SG&A Expense | $76.1M | — | +25.6% |
| Operating Income | -$7.5M | — | -67.2% |
| Income Tax | $84K | — | +189.7% |
| Net Income | -$6.6M | — | -171.6% |
| EPS (Basic) | -$0.07 | — | -133.3% |
| EPS (Diluted) | -$0.07 | — | -133.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $472.9M | -27.5% | -21.1% |
| Total Assets | $2.96B | -0.4% | +29.0% |
| Total Liabilities | $2.23B | +2.4% | +37.6% |
| Stockholders' Equity | $733.2M | -8.2% | +8.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$133.3M | — | -888.4% |
| Capital Expenditures | $2.8M | — | — |
| Investing Cash Flow | $876K | — | +101.1% |
| Financing Cash Flow | $6.7M | — | +115.1% |
| Free Cash Flow | -$136.0M | — | -908.8% |